Efficacy of a PD-1 as an Adjunct Immunotherapy in tuberculosis patients
Latest Information Update: 01 Sep 2023
At a glance
- Drugs Nivolumab (Primary) ; Antituberculars
- Indications Pulmonary tuberculosis
- Focus Therapeutic Use
Most Recent Events
- 24 May 2023 Status changed from not yet recruiting to recruiting, as per presented at the 119th International Conference of the American Thoracic Society
- 19 Jun 2020 New trial record